Loading...

Quick-Med Technologies, Inc.

QMDT•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.00
$-0.00(-0.00%)

Quick-Med Technologies, Inc. (QMDT) Stock Overview

Explore Quick-Med Technologies, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap3.7K
P/E Ratio-0.00
EPS (TTM)N/A
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Week$0.00
1 Month$0.00
3 Months$0.00
1 Year Target$0.00

QMDT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Quick-Med Technologies, Inc. (QMDT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.00 and a market capitalization of 3.7K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for QMDTStats details for QMDT are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for QMDTAnalyst Recommendations details for QMDT are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Quick-Med Technologies, Inc., a life sciences company, focuses on developing and commercializing proprietary broad-based technologies in medical and consumer healthcare markets. It specializes in the research and development of biomedical products and devices for antibacterial applications. The company's core technologies include Novel Intrinsically Micro-Bonded Utility Substrate (NIMBUS), a family of advanced polymers with antimicrobial, hemostatic, and other properties for use in a range of applications; Stay Fresh, a chemical formulation for textiles with a durable antimicrobial agent effective against an array of bacteria; and MultiStat, a family of advanced patented methods and compounds effective in skin therapy applications. It serves government agencies; and healthcare and medical, apparel and textile, and personal care companies. The company was founded in 1997 and is headquartered in Gainesville, Florida.

CEO

Gregory S. Schultz

Employees

5

Headquarters

902 NW 4th Street, Gainesville, FL

Founded

2002

Frequently Asked Questions

;